IHS Chemical Week

Regions :: Western Europe

Lonza and Organobalance Sign License Agreement

12:31 AM MDT | April 19, 2011 | Deepti Ramesh

Lonza says it has signed a worldwide exclusive license agreement with Organobalance (Berlin, Germany), in which Lonza will develop, produce and commercialize products containing a probiotic Lactobacillus strain. Developed by Organobalance, the probiotic strain acts against Helicobacter pylori (H. pylori), which has been implicated as a common cause of peptic ulcers and gastritis. In close cooperation with industry partners, Organobalance develops biological products in the fields of pharmaceutics, preventive health care, nutrition and cosmetics. Organobalance...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa